Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel plus S-1 in locally advanced pancreatic cancer
NCT03815461Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Feb 2019
- Primary completion
- Jun 2023
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel, tegafur in pancreatic cancer (PC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
nab-paclitaxeltegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03815461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03815461.